Gemcitabine hydrochloride is a chemotherapy drug used to treat various types of cancer, including pancreatic, lung, breast, ovarian, and bladder cancer. It is a nucleoside analogue that interferes with the growth and spread of cancer cells in the body. Gemcitabine hydrochloride is typically administered intravenously and works by inhibiting the synthesis of DNA and RNA, thereby preventing cancer cells from dividing and multiplying. It is often used in combination with other chemotherapy drugs to enhance its effectiveness. Common side effects of gemcitabine hydrochloride include nausea, vomiting, fatigue, and low blood cell counts.
The global Gemcitabine Hydrochloride market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gemcitabine Hydrochloride is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gemcitabine Hydrochloride is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Gemcitabine Hydrochloride include Hubei Banbantian Pharmaceutical, Shandong Anhong Pharmaceutical, Shanghai Acebright Pharmaceuticals, Jiangsu Chia Tai Qingjiang Pharmaceutical, ScinoPharm Taiwan, Intas Pharmaceuticals, Euticals, Gland Pharma and SMS Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gemcitabine Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gemcitabine Hydrochloride.
Report Scope
The Gemcitabine Hydrochloride market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gemcitabine Hydrochloride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gemcitabine Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hubei Banbantian Pharmaceutical
Shandong Anhong Pharmaceutical
Shanghai Acebright Pharmaceuticals
Jiangsu Chia Tai Qingjiang Pharmaceutical
ScinoPharm Taiwan
Intas Pharmaceuticals
Euticals
Gland Pharma
SMS Pharmaceuticals
Cipla
Shilpa Medicare
Fresenius Kabi Oncology
Dr Reddy's Laboratories
Teva Pharmaceutical Industries
Hetero Drugs
Emcure Pharmaceuticals
Cadila Pharmaceuticals
Aarti Drugs
Segment by Type
Powder
Solvent
Segment by Application
Cancer
Tumor
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gemcitabine Hydrochloride manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Gemcitabine Hydrochloride by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Gemcitabine Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Gemcitabine Hydrochloride Market Overview
1.1 Product Definition
1.2 Gemcitabine Hydrochloride Segment by Type
1.2.1 Global Gemcitabine Hydrochloride Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Powder
1.2.3 Solvent
1.3 Gemcitabine Hydrochloride Segment by Application
1.3.1 Global Gemcitabine Hydrochloride Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Cancer
1.3.3 Tumor
1.4 Global Market Growth Prospects
1.4.1 Global Gemcitabine Hydrochloride Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Gemcitabine Hydrochloride Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Gemcitabine Hydrochloride Production Estimates and Forecasts (2019-2030)
1.4.4 Global Gemcitabine Hydrochloride Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Gemcitabine Hydrochloride Production Market Share by Manufacturers (2019-2024)
2.2 Global Gemcitabine Hydrochloride Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Gemcitabine Hydrochloride, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Gemcitabine Hydrochloride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Gemcitabine Hydrochloride Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Gemcitabine Hydrochloride, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Gemcitabine Hydrochloride, Product Offered and Application
2.8 Global Key Manufacturers of Gemcitabine Hydrochloride, Date of Enter into This Industry
2.9 Gemcitabine Hydrochloride Market Competitive Situation and Trends
2.9.1 Gemcitabine Hydrochloride Market Concentration Rate
2.9.2 Global 5 and 10 Largest Gemcitabine Hydrochloride Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Gemcitabine Hydrochloride Production by Region
3.1 Global Gemcitabine Hydrochloride Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Gemcitabine Hydrochloride Production Value by Region (2019-2030)
3.2.1 Global Gemcitabine Hydrochloride Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Gemcitabine Hydrochloride by Region (2025-2030)
3.3 Global Gemcitabine Hydrochloride Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Gemcitabine Hydrochloride Production by Region (2019-2030)
3.4.1 Global Gemcitabine Hydrochloride Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Gemcitabine Hydrochloride by Region (2025-2030)
3.5 Global Gemcitabine Hydrochloride Market Price Analysis by Region (2019-2024)
3.6 Global Gemcitabine Hydrochloride Production and Value, Year-over-Year Growth
3.6.1 North America Gemcitabine Hydrochloride Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Gemcitabine Hydrochloride Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Gemcitabine Hydrochloride Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Gemcitabine Hydrochloride Production Value Estimates and Forecasts (2019-2030)
4 Gemcitabine Hydrochloride Consumption by Region
4.1 Global Gemcitabine Hydrochloride Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Gemcitabine Hydrochloride Consumption by Region (2019-2030)
4.2.1 Global Gemcitabine Hydrochloride Consumption by Region (2019-2024)
4.2.2 Global Gemcitabine Hydrochloride Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Gemcitabine Hydrochloride Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Gemcitabine Hydrochloride Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Gemcitabine Hydrochloride Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Gemcitabine Hydrochloride Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Gemcitabine Hydrochloride Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Gemcitabine Hydrochloride Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Gemcitabine Hydrochloride Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Gemcitabine Hydrochloride Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Gemcitabine Hydrochloride Production by Type (2019-2030)
5.1.1 Global Gemcitabine Hydrochloride Production by Type (2019-2024)
5.1.2 Global Gemcitabine Hydrochloride Production by Type (2025-2030)
5.1.3 Global Gemcitabine Hydrochloride Production Market Share by Type (2019-2030)
5.2 Global Gemcitabine Hydrochloride Production Value by Type (2019-2030)
5.2.1 Global Gemcitabine Hydrochloride Production Value by Type (2019-2024)
5.2.2 Global Gemcitabine Hydrochloride Production Value by Type (2025-2030)
5.2.3 Global Gemcitabine Hydrochloride Production Value Market Share by Type (2019-2030)
5.3 Global Gemcitabine Hydrochloride Price by Type (2019-2030)
6 Segment by Application
6.1 Global Gemcitabine Hydrochloride Production by Application (2019-2030)
6.1.1 Global Gemcitabine Hydrochloride Production by Application (2019-2024)
6.1.2 Global Gemcitabine Hydrochloride Production by Application (2025-2030)
6.1.3 Global Gemcitabine Hydrochloride Production Market Share by Application (2019-2030)
6.2 Global Gemcitabine Hydrochloride Production Value by Application (2019-2030)
6.2.1 Global Gemcitabine Hydrochloride Production Value by Application (2019-2024)
6.2.2 Global Gemcitabine Hydrochloride Production Value by Application (2025-2030)
6.2.3 Global Gemcitabine Hydrochloride Production Value Market Share by Application (2019-2030)
6.3 Global Gemcitabine Hydrochloride Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Hubei Banbantian Pharmaceutical
7.1.1 Hubei Banbantian Pharmaceutical Gemcitabine Hydrochloride Corporation Information
7.1.2 Hubei Banbantian Pharmaceutical Gemcitabine Hydrochloride Product Portfolio
7.1.3 Hubei Banbantian Pharmaceutical Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Hubei Banbantian Pharmaceutical Main Business and Markets Served
7.1.5 Hubei Banbantian Pharmaceutical Recent Developments/Updates
7.2 Shandong Anhong Pharmaceutical
7.2.1 Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride Corporation Information
7.2.2 Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride Product Portfolio
7.2.3 Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Shandong Anhong Pharmaceutical Main Business and Markets Served
7.2.5 Shandong Anhong Pharmaceutical Recent Developments/Updates
7.3 Shanghai Acebright Pharmaceuticals
7.3.1 Shanghai Acebright Pharmaceuticals Gemcitabine Hydrochloride Corporation Information
7.3.2 Shanghai Acebright Pharmaceuticals Gemcitabine Hydrochloride Product Portfolio
7.3.3 Shanghai Acebright Pharmaceuticals Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Shanghai Acebright Pharmaceuticals Main Business and Markets Served
7.3.5 Shanghai Acebright Pharmaceuticals Recent Developments/Updates
7.4 Jiangsu Chia Tai Qingjiang Pharmaceutical
7.4.1 Jiangsu Chia Tai Qingjiang Pharmaceutical Gemcitabine Hydrochloride Corporation Information
7.4.2 Jiangsu Chia Tai Qingjiang Pharmaceutical Gemcitabine Hydrochloride Product Portfolio
7.4.3 Jiangsu Chia Tai Qingjiang Pharmaceutical Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Jiangsu Chia Tai Qingjiang Pharmaceutical Main Business and Markets Served
7.4.5 Jiangsu Chia Tai Qingjiang Pharmaceutical Recent Developments/Updates
7.5 ScinoPharm Taiwan
7.5.1 ScinoPharm Taiwan Gemcitabine Hydrochloride Corporation Information
7.5.2 ScinoPharm Taiwan Gemcitabine Hydrochloride Product Portfolio
7.5.3 ScinoPharm Taiwan Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2019-2024)
7.5.4 ScinoPharm Taiwan Main Business and Markets Served
7.5.5 ScinoPharm Taiwan Recent Developments/Updates
7.6 Intas Pharmaceuticals
7.6.1 Intas Pharmaceuticals Gemcitabine Hydrochloride Corporation Information
7.6.2 Intas Pharmaceuticals Gemcitabine Hydrochloride Product Portfolio
7.6.3 Intas Pharmaceuticals Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Intas Pharmaceuticals Main Business and Markets Served
7.6.5 Intas Pharmaceuticals Recent Developments/Updates
7.7 Euticals
7.7.1 Euticals Gemcitabine Hydrochloride Corporation Information
7.7.2 Euticals Gemcitabine Hydrochloride Product Portfolio
7.7.3 Euticals Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Euticals Main Business and Markets Served
7.7.5 Euticals Recent Developments/Updates
7.8 Gland Pharma
7.8.1 Gland Pharma Gemcitabine Hydrochloride Corporation Information
7.8.2 Gland Pharma Gemcitabine Hydrochloride Product Portfolio
7.8.3 Gland Pharma Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Gland Pharma Main Business and Markets Served
7.7.5 Gland Pharma Recent Developments/Updates
7.9 SMS Pharmaceuticals
7.9.1 SMS Pharmaceuticals Gemcitabine Hydrochloride Corporation Information
7.9.2 SMS Pharmaceuticals Gemcitabine Hydrochloride Product Portfolio
7.9.3 SMS Pharmaceuticals Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2019-2024)
7.9.4 SMS Pharmaceuticals Main Business and Markets Served
7.9.5 SMS Pharmaceuticals Recent Developments/Updates
7.10 Cipla
7.10.1 Cipla Gemcitabine Hydrochloride Corporation Information
7.10.2 Cipla Gemcitabine Hydrochloride Product Portfolio
7.10.3 Cipla Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Cipla Main Business and Markets Served
7.10.5 Cipla Recent Developments/Updates
7.11 Shilpa Medicare
7.11.1 Shilpa Medicare Gemcitabine Hydrochloride Corporation Information
7.11.2 Shilpa Medicare Gemcitabine Hydrochloride Product Portfolio
7.11.3 Shilpa Medicare Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Shilpa Medicare Main Business and Markets Served
7.11.5 Shilpa Medicare Recent Developments/Updates
7.12 Fresenius Kabi Oncology
7.12.1 Fresenius Kabi Oncology Gemcitabine Hydrochloride Corporation Information
7.12.2 Fresenius Kabi Oncology Gemcitabine Hydrochloride Product Portfolio
7.12.3 Fresenius Kabi Oncology Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Fresenius Kabi Oncology Main Business and Markets Served
7.12.5 Fresenius Kabi Oncology Recent Developments/Updates
7.13 Dr Reddy's Laboratories
7.13.1 Dr Reddy's Laboratories Gemcitabine Hydrochloride Corporation Information
7.13.2 Dr Reddy's Laboratories Gemcitabine Hydrochloride Product Portfolio
7.13.3 Dr Reddy's Laboratories Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Dr Reddy's Laboratories Main Business and Markets Served
7.13.5 Dr Reddy's Laboratories Recent Developments/Updates
7.14 Teva Pharmaceutical Industries
7.14.1 Teva Pharmaceutical Industries Gemcitabine Hydrochloride Corporation Information
7.14.2 Teva Pharmaceutical Industries Gemcitabine Hydrochloride Product Portfolio
7.14.3 Teva Pharmaceutical Industries Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Teva Pharmaceutical Industries Main Business and Markets Served
7.14.5 Teva Pharmaceutical Industries Recent Developments/Updates
7.15 Hetero Drugs
7.15.1 Hetero Drugs Gemcitabine Hydrochloride Corporation Information
7.15.2 Hetero Drugs Gemcitabine Hydrochloride Product Portfolio
7.15.3 Hetero Drugs Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Hetero Drugs Main Business and Markets Served
7.15.5 Hetero Drugs Recent Developments/Updates
7.16 Emcure Pharmaceuticals
7.16.1 Emcure Pharmaceuticals Gemcitabine Hydrochloride Corporation Information
7.16.2 Emcure Pharmaceuticals Gemcitabine Hydrochloride Product Portfolio
7.16.3 Emcure Pharmaceuticals Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2019-2024)
7.16.4 Emcure Pharmaceuticals Main Business and Markets Served
7.16.5 Emcure Pharmaceuticals Recent Developments/Updates
7.17 Cadila Pharmaceuticals
7.17.1 Cadila Pharmaceuticals Gemcitabine Hydrochloride Corporation Information
7.17.2 Cadila Pharmaceuticals Gemcitabine Hydrochloride Product Portfolio
7.17.3 Cadila Pharmaceuticals Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2019-2024)
7.17.4 Cadila Pharmaceuticals Main Business and Markets Served
7.17.5 Cadila Pharmaceuticals Recent Developments/Updates
7.18 Aarti Drugs
7.18.1 Aarti Drugs Gemcitabine Hydrochloride Corporation Information
7.18.2 Aarti Drugs Gemcitabine Hydrochloride Product Portfolio
7.18.3 Aarti Drugs Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2019-2024)
7.18.4 Aarti Drugs Main Business and Markets Served
7.18.5 Aarti Drugs Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Gemcitabine Hydrochloride Industry Chain Analysis
8.2 Gemcitabine Hydrochloride Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Gemcitabine Hydrochloride Production Mode & Process
8.4 Gemcitabine Hydrochloride Sales and Marketing
8.4.1 Gemcitabine Hydrochloride Sales Channels
8.4.2 Gemcitabine Hydrochloride Distributors
8.5 Gemcitabine Hydrochloride Customers
9 Gemcitabine Hydrochloride Market Dynamics
9.1 Gemcitabine Hydrochloride Industry Trends
9.2 Gemcitabine Hydrochloride Market Drivers
9.3 Gemcitabine Hydrochloride Market Challenges
9.4 Gemcitabine Hydrochloride Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Hubei Banbantian Pharmaceutical
Shandong Anhong Pharmaceutical
Shanghai Acebright Pharmaceuticals
Jiangsu Chia Tai Qingjiang Pharmaceutical
ScinoPharm Taiwan
Intas Pharmaceuticals
Euticals
Gland Pharma
SMS Pharmaceuticals
Cipla
Shilpa Medicare
Fresenius Kabi Oncology
Dr Reddy's Laboratories
Teva Pharmaceutical Industries
Hetero Drugs
Emcure Pharmaceuticals
Cadila Pharmaceuticals
Aarti Drugs
听
听
*If Applicable.
